Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report
<p>Abstract</p> <p>Background</p> <p>Stereotactic body radiation therapy (SBRT) applied by helical tomotherapy (HT) is feasible for lung cancer in clinical. Using SBRT concurrently with erlotinib for non-small cell lung cancer (NSCLC) is not reported previously.</p&g...
Main Authors: | Chen Chien-An, Hsieh Yen-Ping, Wang Li-Ying, Chen Yu-Jen, Lin Shih-Chiang, Chang Hou-Tai, Hsieh Chen-Hsi, Chong Ngot-Swan, Lin Shoei, Chen Chun-Yi, Shueng Pei-Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/696 |
Similar Items
-
Should helical tomotherapy replace brachytherapy for cervical cancer? Case report
by: Chen Yu-Jen, et al.
Published: (2010-11-01) -
Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer
by: Chen Yu-Jen, et al.
Published: (2011-01-01) -
Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma
by: Tai Hung-Chi, et al.
Published: (2010-05-01) -
Treatment of Single or Multiple Brain Metastases by Hypofractionated Stereotactic Radiotherapy Using Helical Tomotherapy
by: Aiko Nagai, et al.
Published: (2014-04-01) -
Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy
by: Rajesh Ashok Kinhikar, et al.
Published: (2015-01-01)